Non-alcoholic Steatohepatitis Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4131262
- 107 Pages
- December 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Non-alcoholic Steatohepatitis market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Non-alcoholic Steatohepatitis market segmented into
Solid
Liquid
Based on the end-use, the global Non-alcoholic Steatohepatitis market classified into
Oral
Parenteral
Based on geography, the global Non-alcoholic Steatohepatitis market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
AstraZeneca
Arena Pharmaceuticals
GSK
Novo Nordisk
Roche
Vivus
Arisaph Pharmaceuticals
Cempra Pharmaceuticals
Galectin Therapeutics
Galmed Pharmaceuticals
Genfit
Gilead
Immuron
Interceptpharma
Raptor Pharmaceutical
Shire
Tobira Therapeutics
Verva
Viking Therapeutics
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL NON-ALCOHOLIC STEATOHEPATITIS INDUSTRY
2.1 Summary about Non-alcoholic Steatohepatitis Industry
2.2 Non-alcoholic Steatohepatitis Market Trends
2.2.1 Non-alcoholic Steatohepatitis Production & Consumption Trends
2.2.2 Non-alcoholic Steatohepatitis Demand Structure Trends
2.3 Non-alcoholic Steatohepatitis Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Solid
4.2.2 Liquid
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Oral
4.3.2 Parenteral
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Solid
5.2.2 Liquid
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Oral
5.3.2 Parenteral
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Solid
6.2.2 Liquid
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Oral
6.3.2 Parenteral
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Solid
7.2.2 Liquid
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Oral
7.3.2 Parenteral
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Solid
8.2.2 Liquid
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Oral
8.3.2 Parenteral
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Solid
9.2.2 Liquid
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Oral
9.3.2 Parenteral
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 AstraZeneca
10.1.2 Arena Pharmaceuticals
10.1.3 GSK
10.1.4 Novo Nordisk
10.1.5 Roche
10.1.6 Vivus
10.1.7 Arisaph Pharmaceuticals
10.1.8 Cempra Pharmaceuticals
10.1.9 Galectin Therapeutics
10.1.10 Galmed Pharmaceuticals
10.1.11 Genfit
10.1.12 Gilead
10.1.13 Immuron
10.1.14 Interceptpharma
10.1.15 Raptor Pharmaceutical
10.1.16 Shire
10.1.17 Tobira Therapeutics
10.1.18 Verva
10.1.19 Viking Therapeutics
10.2 Non-alcoholic Steatohepatitis Sales Date of Major Players (2017-2020e)
10.2.1 AstraZeneca
10.2.2 Arena Pharmaceuticals
10.2.3 GSK
10.2.4 Novo Nordisk
10.2.5 Roche
10.2.6 Vivus
10.2.7 Arisaph Pharmaceuticals
10.2.8 Cempra Pharmaceuticals
10.2.9 Galectin Therapeutics
10.2.10 Galmed Pharmaceuticals
10.2.11 Genfit
10.2.12 Gilead
10.2.13 Immuron
10.2.14 Interceptpharma
10.2.15 Raptor Pharmaceutical
10.2.16 Shire
10.2.17 Tobira Therapeutics
10.2.18 Verva
10.2.19 Viking Therapeutics
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
Table Non-alcoholic Steatohepatitis Product Type Overview
Table Non-alcoholic Steatohepatitis Product Type Market Share List
Table Non-alcoholic Steatohepatitis Product Type of Major Players
Table Brief Introduction of AstraZeneca
Table Brief Introduction of Arena Pharmaceuticals
Table Brief Introduction of GSK
Table Brief Introduction of Novo Nordisk
Table Brief Introduction of Roche
Table Brief Introduction of Vivus
Table Brief Introduction of Arisaph Pharmaceuticals
Table Brief Introduction of Cempra Pharmaceuticals
Table Brief Introduction of Galectin Therapeutics
Table Brief Introduction of Galmed Pharmaceuticals
Table Brief Introduction of Genfit
Table Brief Introduction of Gilead
Table Brief Introduction of Immuron
Table Brief Introduction of Interceptpharma
Table Brief Introduction of Raptor Pharmaceutical
Table Brief Introduction of Shire
Table Brief Introduction of Tobira Therapeutics
Table Brief Introduction of Verva
Table Brief Introduction of Viking Therapeutics
Table Products & Services of AstraZeneca
Table Products & Services of Arena Pharmaceuticals
Table Products & Services of GSK
Table Products & Services of Novo Nordisk
Table Products & Services of Roche
Table Products & Services of Vivus
Table Products & Services of Arisaph Pharmaceuticals
Table Products & Services of Cempra Pharmaceuticals
Table Products & Services of Galectin Therapeutics
Table Products & Services of Galmed Pharmaceuticals
Table Products & Services of Genfit
Table Products & Services of Gilead
Table Products & Services of Immuron
Table Products & Services of Interceptpharma
Table Products & Services of Raptor Pharmaceutical
Table Products & Services of Shire
Table Products & Services of Tobira Therapeutics
Table Products & Services of Verva
Table Products & Services of Viking Therapeutics
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Non-alcoholic Steatohepatitis Market Forecast (Million USD) by Region 2021f-2026f
Table Global Non-alcoholic Steatohepatitis Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Non-alcoholic Steatohepatitis Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Non-alcoholic Steatohepatitis Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
